BARRY FLIPPO: Open Payments
NPI 1659844595 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,570 in 93 payments from 19 companies in 2025. Trend: 2023 $2,361 · 2024 $2,473 · 2025 $2,570
Food & beverage: $2,505Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $529 |
| Novartis Pharmaceuticals Corporation | 9 | $311 |
| LEO Pharma Inc. | 9 | $297 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $250 |
| Regeneron Healthcare Solutions, Inc. | 7 | $246 |
| Janssen Biotech, Inc. | 7 | $210 |
| GENZYME CORPORATION | 7 | $185 |
| E.R. Squibb & Sons, L.L.C. | 2 | $152 |
| Organogenesis Inc. | 3 | $88 |
| Incyte Corporation | 2 | $47 |
Products named: SKYRIZI, DUPIXENT, ADBRY, TREMFYA, ILUMYA, Sotyktu, Rhapsido, COSENTYX.
Industry payments across MS — which companies pay providers there.
